“According to the latest figures released by the NHS, dementia diagnosis is at a record high in England. ... Pharmacist cautions against self-medicating with ozempic for dementia risk reduction.

New research suggests that semaglutide, the active ingredient in GLP-1 drugs like Ozempic and Wegovy, might protect against dementia. More than 6 million Americans are diagnosed with dementia each ...

But up to half of all dementia cases might be preventable, and scientists have identified over a dozen modifiable risk factors that contribute to dementia risk, including obesity, type 2 diabetes ...

Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new study suggests. Researchers found these medications show promise in ...

Ozempic May Lower Your Dementia Risk, New Study Suggests. A Neurologist Explains The Potential Link. It all has to do with inflammation. By Korin Miller Published: Jan 21, 2025 12:01 PM EST.

Ozempic use is associated with a lowered risk for cognitive problems, researchers in a new study said. The findings, however, cannot be applied to users who do not have diabetes. The study ...

Ozempic could cut the risk of dementia by half, a University of Oxford study has suggested. Scientists set out to establish the impact of the weight-loss jab on the brain in the first study of its ...

The study, published in the Lancet's eClinicalMedicine journal on Thursday, explored more than 100 million medical records of U.S. patients to see if Ozempic increased the risk of several ...

Not one but two new studies published today have linked GLP-1 drugs like Ozempic to a decreased risk of developing dementia. There is currently no cure for Alzheimer’s, which affects an ...

Novo Nordisk A/S’s Ozempic was linked to lower rates of dementia and a range of other mental problems in a University of Oxford study that raises expectations about the diabetes drug’s ...